Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

QuidelOrtho Corporation (QDEL) Cash Flow Statement

QuidelOrtho Corporation (QDEL) generated -$57.2M of operating cash flow over the twelve months to 2026-06-30, spent $154.0M on capital expenditure and had free cash flow of -$211.2M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

QDELQuidelOrtho CorporationFollow QDEL — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
941.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 9 days
LineFY2022
Jan 23
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow0.890.280.080.11-0.06
Capital expenditure0.140.210.200.19-0.15
Free cash flow0.740.07-0.11-0.08-0.21
Share repurchases0.070.010.000.00—
Stock-based compensation0.050.050.040.05—

USD billions · SEC XBRL

QuidelOrtho Corporation — questions

What is QuidelOrtho Corporation's operating cash flow?
-$57.2M over the twelve months to 2026-06-30.
How much does QuidelOrtho Corporation spend on capital expenditure?
$154.0M over the twelve months to 2026-06-30.
What is QuidelOrtho Corporation's free cash flow?
-$211.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from QuidelOrtho Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.